Fast Market Research

Heat Biologics, Inc. - Product Pipeline Review - 2013 - New Report Available

Recently published research from Global Markets Direct, "Heat Biologics, Inc. - Product Pipeline Review - 2013", is now available at Fast Market Research

 

Boston, MA -- (ReleaseWire) -- 02/12/2014 -- Global Market Direct's pharmaceuticals report, "Heat Biologics, Inc. - Product Pipeline Review - 2013" provides data on the Heat Biologics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Heat Biologics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Heat Biologics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Heat Biologics, Inc. - Brief Heat Biologics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Heat Biologics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Heat Biologics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Heat Biologics, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Heat Biologics, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Heat Biologics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Heat Biologics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Heat Biologics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Heat Biologics, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Heat Biologics, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Synthetic Biologics, Inc. - Product Pipeline Review - 2013
- TaiMed Biologics Inc. - Product Pipeline Review - 2013
- Avaxia Biologics, Inc. - Product Pipeline Review - 2013
- Qu Biologics Inc. - Product Pipeline Review - 2013
- Johnson & Johnson - Product Pipeline Review - 2013
- Cancer Pain - Pipeline Review, H2 2013
- Biotest AG - Product Pipeline Review - 2013
- Celsion Corporation - Product Pipeline Review - 2013
- Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2013
- Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013